Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC); compare to the active ingredient in Pataday2 Twice Daily Relief.